A detailed history of Certified Advisory Corp transactions in Abbott Laboratories stock. As of the latest transaction made, Certified Advisory Corp holds 5,725 shares of ABT stock, worth $671,313. This represents 0.07% of its overall portfolio holdings.

Number of Shares
5,725
Previous 5,990 4.42%
Holding current value
$671,313
Previous $622,000 4.82%
% of portfolio
0.07%
Previous 0.08%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$100.07 - $118.13 $26,518 - $31,304
-265 Reduced 4.42%
5,725 $652,000
Q2 2024

Aug 13, 2024

BUY
$100.73 - $112.44 $603,372 - $673,515
5,990 New
5,990 $622,000
Q4 2023

Feb 09, 2024

BUY
$90.19 - $110.4 $547,543 - $670,238
6,071 New
6,071 $668,000
Q1 2023

May 15, 2023

SELL
$96.86 - $114.01 $8,233 - $9,690
-85 Reduced 1.41%
5,956 $603,000
Q4 2022

Feb 14, 2023

BUY
$95.06 - $111.52 $8,080 - $9,479
85 Added 1.43%
6,041 $663,000
Q3 2022

Nov 14, 2022

BUY
$96.76 - $112.03 $18,674 - $21,621
193 Added 3.35%
5,956 $576,000
Q2 2022

Aug 15, 2022

SELL
$102.07 - $123.37 $58,179 - $70,320
-570 Reduced 9.0%
5,763 $626,000
Q1 2022

May 13, 2022

BUY
$114.02 - $139.04 $1,368 - $1,668
12 Added 0.19%
6,333 $750,000
Q4 2021

Feb 14, 2022

BUY
$115.53 - $141.46 $52,566 - $64,364
455 Added 7.76%
6,321 $890,000
Q3 2021

Nov 15, 2021

BUY
$116.66 - $129.06 $3,849 - $4,258
33 Added 0.57%
5,866 $693,000
Q2 2021

Aug 16, 2021

BUY
$105.79 - $124.53 $1,481 - $1,743
14 Added 0.24%
5,833 $676,000
Q1 2021

May 10, 2021

BUY
$108.84 - $128.23 $78,909 - $92,966
725 Added 14.23%
5,819 $697,000
Q2 2020

Jul 27, 2020

BUY
$76.57 - $98.0 $96,248 - $123,186
1,257 Added 32.76%
5,094 $466,000
Q1 2020

Apr 27, 2020

SELL
$62.82 - $91.86 $8,983 - $13,135
-143 Reduced 3.59%
3,837 $303,000
Q4 2019

Jan 29, 2020

BUY
$78.51 - $87.4 $549 - $611
7 Added 0.18%
3,980 $346,000
Q3 2019

Nov 12, 2019

BUY
$81.84 - $88.74 $53,768 - $58,302
657 Added 19.81%
3,973 $332,000
Q2 2019

Aug 07, 2019

BUY
$72.88 - $85.0 $583 - $680
8 Added 0.24%
3,316 $279,000
Q1 2019

May 07, 2019

BUY
$66.22 - $80.06 $44,234 - $53,480
668 Added 25.3%
3,308 $264,000
Q4 2018

Feb 04, 2019

BUY
$65.56 - $74.27 $5,441 - $6,164
83 Added 3.25%
2,640 $191,000
Q3 2018

Nov 13, 2018

SELL
$60.81 - $73.36 $5,594 - $6,749
-92 Reduced 3.47%
2,557 $188,000
Q2 2018

Aug 14, 2018

BUY
$57.57 - $63.54 $6,275 - $6,925
109 Added 4.29%
2,649 $155,000
Q1 2018

Apr 30, 2018

BUY
$56.27 - $63.62 $506 - $572
9 Added 0.36%
2,540 $152,000
Q4 2017

Feb 22, 2018

BUY
$53.68 - $57.47 $135,864 - $145,456
2,531
2,531 $144,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $205B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Certified Advisory Corp Portfolio

Follow Certified Advisory Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Certified Advisory Corp, based on Form 13F filings with the SEC.

News

Stay updated on Certified Advisory Corp with notifications on news.